Učitavanje...
Autoimmunogenicity during anti-TNF therapy in patients with psoriasis and psoriatic arthritis
INTRODUCTION: The tumor necrosis factor (TNF-α) was initially described as lymphotoxin or cachectin. The discovery of therapies blocking the action of TNF-α, in 1988, started a new era in the therapy. One of often reported adverse effects related to the use of TNF-α antagonists is induction of the f...
Spremljeno u:
| Izdano u: | Postepy Dermatol Alergol |
|---|---|
| Glavni autori: | , , , , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Termedia Publishing House
2015
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4565839/ https://ncbi.nlm.nih.gov/pubmed/26366147 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5114/pdia.2015.53320 |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|